ArticleDiabetes, obesity & metabolism2026

Dose-Response Association Between Systemic and Dermatologic Glucocorticoid Use and Type 2 Diabetes Mellitus: A Nationwide Case-Control Study.

David Vadsholt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.